Clinical Study on the Efficacy and Safety of Scalp Med in Patients with Androgenetic Alopecia

    June 2008 in “ 대한피부과학회지 ”
    유박린, 심우영, 허창훈, 박장규
    TLDR Scalp med(R) effectively and safely improves hair count and thickness in men with androgenetic alopecia.
    This clinical study evaluated the effectiveness and safety of Scalp medⓇ, a topical solution containing minoxidil, retinol, polysorbate 80, and phytosterol, in treating androgenetic alopecia (AGA) in males aged 20 to 60 years with mild to moderate AGA. Over 24 weeks, all participants showed significant improvement in hair count and hair thickness, demonstrating a highly positive response to the treatment. The study concluded that Scalp medⓇ is effective and safe for treating AGA.
    Discuss this study in the Community →